Platelet Methylene Reductase Activity in Schizophrenia

Authors:
  • PBPhilip A. Berger
    Philip A. Berger
  • GEGlen R. Elliott
    Glen R. Elliott
  • EEElizabeth Erdelyi
    Elizabeth Erdelyi
  • SWStanley J. Watson
    Stanley J. Watson
  • RWRichard Jed Wyatt
    Richard Jed Wyatt
  • JBJack D. Barchas
    Jack D. Barchas

Abstract
• A case of a folate-responsive psychosis that was associated with a defect in N5.10-methylenetetrahydrofolate reductase (methylene reductase) suggested the need to examine whether abnormally low activity of this enzyme might be of etiological importance in schizophrenia. We now report that there were no statistically significant differences in the platelet methylene reductase activity of chronic schizophrenics, compared with either hospitalized or nonhospitalized age-matched control subjects. Although it is possible that a larger survey might reveal a subpopulation of schizophrenics who are characterized by abnormal methylene reductase activity, this study suggests that chronic schizophrenia is not generally associated with such changes.

This publication has 9 references indexed in Scilit: